Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benefix in Hemophilia B
NCT00581126Phase 4Completed
- Sponsor
- Pfizer
- Start
- Dec 2001
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of coagulation factor ix recombinant in hemophilia B (HB), sponsored by Pfizer. Started Dec 2001; status: completed.
02
Drugs
coagulation factor ix recombinant
03
Conditions
hemophilia B (HB)
Beyond the preview
Go deeper on NCT00581126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00581126.